Human Genome lupus drug draws questions; stock off
(Reuters)
Unusual Little Blurbs
Reuters - U.S. Drug reviewers asked if the benefits of a long-awaited Human Genome Sciences Inc lupus drug outweighed concerns about suicide and other possible risks, but analysts said they still expected approval.
Source: Yahoo! News: Biotechnology News
Brain microstructural damage related to cognitive dysfunction and steroid medication in lupus patients. Researchers attempted to unravel such mechanisms by adopting non-invasive diffusion magnetic resonance imaging (MRI) to study the brains of SLE patients, particularly the white matter, coupled with computerized neuropsychological assessment. White matter lies beneath the grey matter cortex in the human brain and comprises millions of bundles of nerve fibers that transmit signals to different brain regions. Source 3l.